UKIPO trademark

RYVIZLA

FiledUKIPOWord markClass 5

"RYVIZLA" is a word mark owned by Viridian Therapeutics, Inc., filed at the UKIPO on September 16, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

Official UKIPO record
RYVIZLA
Word mark as filed with the UKIPO
Status
Filed
Since September 16, 2026
Filed
September 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
UK00004446124
Registration no.
UK00004446124
Office
UKIPO
Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns RYVIZLA

The owner and representative on file with the office.

Owner

Viridian Therapeutics, Inc.

United States

Representative

Fox Williams LLP

Fox Williams LLP

Goods and services

What the mark covers

The products and services RYVIZLA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders.

FAQ

About RYVIZLA

Who owns the trademark "RYVIZLA"?

The UKIPO trademark "RYVIZLA" (application UK00004446124) is owned by Viridian Therapeutics, Inc.

What is the status of "RYVIZLA"?

Its status at the UKIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RYVIZLA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a0ad6d-6144-75bb-b574-d7ce41540367
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0ad6d-6144-75bb-b574-d7ce41540367",
  "object": "trademark",
  "mark_text": "RYVIZLA",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "GB",
  "application_number": "UK00004446124",
  "filing_date": "2026-09-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Viridian Therapeutics, Inc.",
      "entity_id": null
    }
  ]
}